Travere Therapeutics Inc. (TVTX)
NASDAQ: TVTX
· Real-Time Price · USD
18.82
0.59 (3.24%)
At close: Aug 15, 2025, 3:59 PM
19.25
2.28%
After-hours: Aug 15, 2025, 05:00 PM EDT
Travere Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 75.15M | 61.9M | 58.53M | 36.41M | 32.29M | 43.25M | 58.18M | 144.24M | 70.87M | 161.38M | 61.69M | 151.34M | 179.76M | 256.57M | 165.75M | 150.33M | 83.29M | 148.23M |
Short-Term Investments | 244.38M | 260.35M | 312.17M | 241.03M | 293.11M | 397.79M | 508.68M | 490.4M | 420.46M | 400.14M | 388.56M | 354.99M | 373.41M | 346.82M | 387.13M | 400.86M | 439.5M | 372.64M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 53.24M | 52.76M | 53.77M | 53.64M | 53.88M | 57.08M | 42.11M | 12.91M | 11.79M | 11.03M | 11.06M | 11.09M | 10.81M | 10.83M | 11.07M | 34.87M | 34.36M | 35.03M |
Receivables | 38.72M | 34.38M | 27.12M | 25.17M | 24.47M | 22.73M | 21.18M | 14.57M | 20.4M | 21.54M | 16.65M | 12.67M | 16.69M | 14.68M | 15.91M | 13.78M | 12.26M | 30.24M |
Inventory | 4.09M | 3.93M | 6.2M | 6.36M | 5.98M | 4.53M | 9.41M | 20.77M | 18.77M | 6.71M | 6.92M | 7.3M | 7.63M | 6.52M | 7.31M | 6.62M | 7.41M | 7.18M |
Other Current Assets | 17.22M | 13.62M | 12.69M | 15.78M | 13.14M | 12.77M | 19.34M | 16.24M | 11.56M | 15.14M | 12.62M | 8.55M | 9.28M | 6.51M | 247K | n/a | n/a | n/a |
Total Current Assets | 379.57M | 374.17M | 416.7M | 324.74M | 368.98M | 481.08M | 616.77M | 686.23M | 542.05M | 604.9M | 486.44M | 534.84M | 586.78M | 631.09M | 582.83M | 579.08M | 549.8M | 565.04M |
Property-Plant & Equipment | 16.9M | 18.05M | 19.63M | 21.82M | 23.05M | 24.21M | 25.54M | 26.8M | 28.13M | 29.42M | 30.05M | 30.81M | 31.99M | 33.16M | 34.3M | 11.51M | 11.72M | 11.7M |
Goodwill & Intangibles | 105.61M | 103.82M | 104.02M | 104.2M | 105.22M | 101.23M | 104.49M | 106.9M | 154.42M | 162.88M | 145.04M | 149.43M | 149.88M | 153.32M | 148.44M | 149.61M | 150.89M | 152.28M |
Total Long-Term Assets | 175.74M | 174.63M | 177.42M | 179.67M | 182.14M | 182.52M | 172.14M | 146.62M | 194.34M | 203.33M | 186.15M | 191.34M | 192.68M | 197.31M | 193.81M | 196M | 196.97M | 199M |
Total Assets | 555.31M | 548.8M | 594.13M | 504.41M | 551.12M | 663.55M | 788.91M | 832.85M | 736.43M | 808.23M | 672.59M | 726.22M | 779.49M | 828.4M | 776.63M | 775.08M | 746.77M | 764.04M |
Account Payables | 19.13M | 15.37M | 23.53M | 23.2M | 25.84M | 16.73M | 41.67M | 24.74M | 19.91M | 16.73M | 17.29M | 14.01M | 11.85M | 18.43M | 15.14M | 5.83M | 8.34M | 15.01M |
Deferred Revenue | n/a | n/a | 2.81M | 3.8M | 5.38M | 6.46M | 7.1M | 8.96M | 10.24M | 10.97M | 11.98M | 11.38M | 12.5M | 14.23M | 16.27M | 16.07M | -2.62M | -1.09M |
Short-Term Debt | 74.43M | 68.76M | 68.68M | 73.9M | 5.16M | n/a | 4.91M | 4.78M | 4.66M | 4.54M | n/a | 4.23M | 4.12M | 4.01M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 95.97M | 98.33M | 49.46M | 55.56M | 57.22M | 126.29M | 89.41M | 69.33M | 74.74M | 67.01M | 73.2M | 67.19M | 69.02M | 55.37M | 62.77M | 44.85M | 75.98M | 60.08M |
Total Current Liabilities | 189.54M | 182.46M | 200.75M | 190.04M | 121.27M | 173.23M | 177.91M | 139.43M | 135.71M | 130.65M | 142.16M | 131.03M | 124.49M | 119.47M | 124.09M | 113.16M | 96.98M | 85.01M |
Long-Term Debt | 325.14M | 310.66M | 310.31M | 309.96M | 378.13M | 377.69M | 377.26M | 400.7M | 401.51M | 402.3M | 375.55M | 403.38M | 404.05M | 404.77M | 226.58M | 223.7M | 220.86M | 218.08M |
Other Long-Term Liabilities | 7.88M | 22.86M | 6.8M | 16.29M | 16.64M | 16.38M | 8.48M | -15.48M | 50.83M | 51.04M | 73.58M | 49.94M | 48.65M | 45.91M | 71.98M | 74.26M | 63.71M | 67.06M |
Total Long-Term Liabilities | 333.02M | 333.52M | 334.3M | 344.83M | 414.71M | 416.25M | 410.19M | 413.65M | 484.23M | 488.45M | 487.57M | 494.51M | 498.29M | 500.79M | 350.43M | 354.54M | 317.49M | 316.34M |
Total Liabilities | 522.56M | 515.98M | 535.05M | 534.86M | 535.97M | 589.48M | 588.1M | 553.08M | 619.94M | 619.09M | 629.73M | 625.54M | 622.78M | 620.26M | 474.52M | 467.7M | 414.46M | 401.36M |
Total Debt | 399.57M | 400.46M | 401.58M | 402.43M | 403.23M | 404.02M | 404.78M | 405.48M | 406.17M | 406.85M | 407.49M | 407.62M | 408.17M | 408.79M | 261.99M | 223.7M | 220.86M | 218.08M |
Common Stock | 9K | 9K | 9K | 8K | 8K | 8K | 7K | 7K | 7K | 7K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K |
Retained Earnings | -1.5B | -1.49B | -1.45B | -1.39B | -1.33B | -1.26B | -1.13B | -1.04B | -1.19B | -1.1B | -1.01B | -948.4M | -878.74M | -811.71M | -765.97M | -714.39M | -678.75M | -639.74M |
Comprehensive Income | -812K | -843K | -80K | -1.02M | -1.63M | -1.89M | -1.46M | -3.65M | -3.85M | -2.18M | -2.91M | 303K | -1.08M | -1.7M | -562K | -525K | -641K | -262K |
Shareholders Equity | 32.75M | 32.82M | 59.08M | -30.45M | 15.15M | 74.07M | 200.81M | 279.77M | 116.48M | 189.14M | 42.85M | 100.68M | 156.71M | 208.14M | 302.11M | 307.37M | 332.3M | 362.69M |
Total Investments | n/a | 260.35M | 312.17M | 241.03M | 293.11M | 397.79M | 508.68M | 490.4M | 420.46M | 400.14M | 388.56M | 354.99M | 373.41M | 346.82M | 387.13M | 400.86M | 439.5M | 372.64M |